SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-003549
Filing Date
2022-03-14
Accepted
2022-03-14 16:31:00
Documents
43
Period of Report
2022-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sgtx-20220314x8k.htm   iXBRL 8-K 40875
2 EX-99.1 sgtx-20220314xex99d1.htm EX-99.1 217991
3 EX-99.2 sgtx-20220314xex99d2.htm EX-99.2 45222
4 GRAPHIC sgtx-20220314xex99d1001.jpg GRAPHIC 5781
5 GRAPHIC sgtx-20220314xex99d2g003.jpg GRAPHIC 106191
6 GRAPHIC sgtx-20220314xex99d2g008.jpg GRAPHIC 182034
7 GRAPHIC sgtx-20220314xex99d2g024.jpg GRAPHIC 174572
8 GRAPHIC sgtx-20220314xex99d2g012.jpg GRAPHIC 142188
9 GRAPHIC sgtx-20220314xex99d2g007.jpg GRAPHIC 184777
10 GRAPHIC sgtx-20220314xex99d2g014.jpg GRAPHIC 242738
11 GRAPHIC sgtx-20220314xex99d2g005.jpg GRAPHIC 139881
12 GRAPHIC sgtx-20220314xex99d2g022.jpg GRAPHIC 162304
13 GRAPHIC sgtx-20220314xex99d2g009.jpg GRAPHIC 177403
14 GRAPHIC sgtx-20220314xex99d2g025.jpg GRAPHIC 191520
15 GRAPHIC sgtx-20220314xex99d2g020.jpg GRAPHIC 145628
16 GRAPHIC sgtx-20220314xex99d2g021.jpg GRAPHIC 161056
17 GRAPHIC sgtx-20220314xex99d2g027.jpg GRAPHIC 146303
18 GRAPHIC sgtx-20220314xex99d2g002.jpg GRAPHIC 351088
19 GRAPHIC sgtx-20220314xex99d2g023.jpg GRAPHIC 152378
20 GRAPHIC sgtx-20220314xex99d2g013.jpg GRAPHIC 159112
21 GRAPHIC sgtx-20220314xex99d2g010.jpg GRAPHIC 128530
22 GRAPHIC sgtx-20220314xex99d2g011.jpg GRAPHIC 173875
23 GRAPHIC sgtx-20220314xex99d2g016.jpg GRAPHIC 160399
24 GRAPHIC sgtx-20220314xex99d2g017.jpg GRAPHIC 203970
25 GRAPHIC sgtx-20220314xex99d2g019.jpg GRAPHIC 165801
26 GRAPHIC sgtx-20220314xex99d2g006.jpg GRAPHIC 146644
27 GRAPHIC sgtx-20220314xex99d2g004.jpg GRAPHIC 147099
28 GRAPHIC sgtx-20220314xex99d2g026.jpg GRAPHIC 121753
29 GRAPHIC sgtx-20220314xex99d2g015.jpg GRAPHIC 145352
30 GRAPHIC sgtx-20220314xex99d2g028.jpg GRAPHIC 90258
31 GRAPHIC sgtx-20220314xex99d2g001.jpg GRAPHIC 101881
32 GRAPHIC sgtx-20220314xex99d2g018.jpg GRAPHIC 158403
  Complete submission text file 0001558370-22-003549.txt   6755444

Data Files

Seq Description Document Type Size
33 EX-101.SCH sgtx-20220314.xsd EX-101.SCH 3031
34 EX-101.LAB sgtx-20220314_lab.xml EX-101.LAB 16735
35 EX-101.PRE sgtx-20220314_pre.xml EX-101.PRE 10609
37 EXTRACTED XBRL INSTANCE DOCUMENT sgtx-20220314x8k_htm.xml XML 5053
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Filer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39746 | Film No.: 22737035
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences